Detection of myelin basic protein in cerebrospinal fluid

References

• Norton Wt. Formation, structure and biochemistry of myelin. In: Basic Neurochemistry (3rd Ed.) Seigel GJ, Albers, RW, Agranoff BW, Karzman RI; (Eds.), Litde Brown, Boston, MA, USA 63-92(1981).
   Google Scholar
• Cohen SR, Hemdon RM, McKhann GM. Radioimmunoassay of myelin basic protein in spinal fluid: an index of active demyelination. N Engl. J. Med 295, 1455–1457 (1976).
   Google Scholar
• •One of the RIA reports in which patients with active demyelinating diseases had high levels of MBP, and also patients with mutiple sclerosis had high levels of MBP in acute exacerbation and low levels in remission.
   Google Scholar
• Whitaker JN. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 27, 911–920 (1977).
   PubMed Web of Science ®Google Scholar
• •Reports a double-antibody RIA system measuring MBP in unconcentrated CSE
   Google Scholar
• Carson JH, Barbarese E, Braun PE, McPherson TA. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein. Proc. Nad Acad. Sci. USA 75, 1976–1978 (1978).
   PubMedGoogle Scholar
• Whitaker JN, Bashir RM, Chou C-HJ, Kibler RE Antigenic features of myelin basic protein-like material in cerebrospinal fluid." Immunot 124, 1148–1153 (1980).
   Google Scholar
• Ohta M, Matsubara F, Konishi T, Nishitani H. Radioimmunoassay of myelin basic protein in cerebrospinal fluid and its clinical application to patients with neurological diseases. Lifi Sci. 27, 1069–1074 (1980).
   PubMedGoogle Scholar
• •Reports a RIA system capable of measuring a MBP concentration as low as 500 ng/l.
   Google Scholar
• Cohen SR, Brooks BR, Herndon RM, McKhann GM. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann. Neurot 8, 25–31 (1980).
   PubMed Web of Science ®Google Scholar
• Englert AB, Dommasch D, Hempel K. Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.' Neura 225, 231–236 (1981).
   Google Scholar
• Sellebj erg F, Christiansen M, Nielsen PM, Frederiksen JL Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis. Mult. Scler. 4, 475–479 (1998).
   PubMedGoogle Scholar
• Whitaker JN. Myelin basic protein in cerebrospinal fluid and other body fluids. Mult. Scler. 4, 16–21 (1998).
   PubMed Web of Science ®Google Scholar
• •One of the review of MBP in CSF and other body fluids.
   Google Scholar
• Ohta M, Ohta K, Ma J et al. Clinical and analytical evaluation of an enzyme immunoassay for myelin basic protein in cerebrospinal fluid. Clin. Chem. 46, 1326–1330 (2000).
   PubMedGoogle Scholar
• •First report for an ELISA system measuring MBP in CSF with a detection limit of 30 ng/l. This convenient ELISA is a good indicator of MS disease activity.
   Google Scholar
• Roman GC. The neuroepidemiology of tropical spastic paraparesis. Ann. Neural. 23(Suppl.), 113–120 (1988).
   Google Scholar
• Tournier-Lasserve E, Gout 0, Gessain A et aZ HTLV-I, brain abnormalities on magnetic resonance imaging and relation with multiple sclerosis. Lancet 2, 49–50 (1987).
   PubMedGoogle Scholar
• Osame M, Matsumoto M, Usuki K et al. Chronic progressive myelopathy associated with elevated antibodies to human T lymphotropic virus Type I and adult T-cell leukemia like cells. Ann. Neural. 21, 117–122 (1987).
   PubMed Web of Science ®Google Scholar
• Vernant JC, Maurs L, Gessain A et al. Endemic tropical spastic paraparesis associated with humanT-lymphotropic virus Type I: a clinical and seroepidemiological study of 25 cases. Ann. Neurot 21, 123–130 (1987).
   Google Scholar
• Ohta M, Ohta K, Nishimura M, Saida T. Detection of myelin basic protein in CSF and serum from patients with HTLV-I associated myelopathy/tropical spastic paraparesis. Ann. Clin Biochem. (In Press).
   Google Scholar
• Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139–165 (1972).
   Google Scholar
• Eylar EH, Brostoff S, Hashim G, Caccam J, Burnett P. Basic Al protein of the myelin membrane. The complete amino acid sequence.' Bid Chem. 246, 5770–5784 (1971).
   Google Scholar
• McPherson TA, Gilpin A, Seland TB Radioimmunoassay of CSF for encephalitogenic basic protein: a diagnost test for MS? Can. Med. Assoc. J. 10, 856–859 (1972).
   Google Scholar
• Murase K, Takeuchi R, Furukawa S, Hayashi K. Highly sensitive enzyme immunoassay for b-nerve growth factor (NGF): a tool for measurement of NGF in rat serum. Biochem. Int. 22, 807–813 (1990).
   PubMedGoogle Scholar
• Jacque C, Delassalle A, Rancurel G, Raoul M, Lesourd B, Legrand J-C. Myelin basic protein in CSF and blood: relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients. Arch. 1Veurol 39, 557–560 (1982).
   Google Scholar
• Ohta M, Nishitani H, Matsubara F, Inaba G. Myelin basic protein in spinal fluid from patients with neuro-Behcet's disease [LETTER]. New. Engl J. Med. 302, 1093 (1980).
   PubMedGoogle Scholar
• Nakagawa H, Yamada M, Kanayama T et al. Myelin basic protein in the cerebrospinal fluid of patients with brain tumors. Neurosurgery 34, 825–833 (1994).
   PubMed Web of Science ®Google Scholar
• van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GE Age-related changes of neuron-specific enolase, S-100 protein and myelin basic protein concentrations in cerebrospinal fluid. Clin. Chem. 38, 813–816 (1992).
   Google Scholar
• Filippi M. Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118, 1601–1612 (1995).
   Google Scholar